Centre for Drug Discovery staff
We are a group of academics and postdoctoral researchers from the fields of chemistry and life sciences.
Centre for Drug Discovery
Developing the technologies that accelerate next-generation drug discovery.
Our research
From creating new chemical matter and next-generation screening technologies to understanding disease biology, we develop enabling approaches that advance therapeutic discovery.
Enabling the future of drug discovery
The Bath Centre for Drug Discovery unites researchers from Chemistry, Life Sciences and Computer Science to create the technologies that drive next-generation therapeutic discovery.
Our mission is to transform medicine discovery through innovative platforms and methods that support every stage of the drug discovery process. We combine expertise in synthetic chemistry, AI/ML, advanced computation, screening technologies, and chemical, structural and systems biology to develop widely applicable discovery tools. These technologies can be applied to major therapeutic challenges, including cancer, infectious diseases, antimicrobial resistance and neurodegenerative disorders.
Through shared infrastructure, industry collaboration and international partnerships, we translate fundamental research into partner-ready technologies, screening platforms, chemical probes and lead molecules that accelerate therapeutic discovery across academia, biotechnology and the pharmaceutical industry.
Our people
Meet the staff in the Centre for Drug Discovery.
Latest news
Find out all about the latest news in our centre.
Bath drug discovery spin-out wins national Emerging Technologies Competition
Revolver Therapeutics has won the health category of the Royal Society of Chemistry's Emerging Technologies Competition 2026.
Latest projects
Read about our latest research activities and projects.
New therapeutic strategies for difficult-to-treat cancers
Developing next-generation molecules and screening technologies to unlock new cancer treatments.
Stabilising alpha-synuclein to prevent toxic protein aggregation
Developing ultra-stable constrained peptides to block toxic alpha-synuclein aggregation in Parkinson’s disease and Lewy body dementia.
Understanding type 2 diabetes treatments: why don't they work for everyone?
Investigating how oxidative damage inside our cells alters key diabetes drug targets and how that knowledge could lead to individually tailored treatments.
Developing intracellular peptide technologies to target undruggable transcription factors
Creating new intracellular screening technologies to discover constrained peptide molecules that can block disease-driving transcription factors.
Understanding antibiotic action and resistance in Klebsiella pneumoniae
Improving our understanding of how key antibiotics work and how resistance develops in Klebsiella pneumoniae.
A bio-based solution to sustainable cyclic peptide production and drug discovery
Developing sustainable bio-based technologies to rapidly discover and produce next-generation cyclic peptide therapeutics.
Where to find us
Our offices can be found across the University Campus:
- Department of Life Sciences (4 South, 5 West, 7 West, Centre for Evolution)
- Department of Chemistry (1 South, 5 West)
Contact us
If you have any questions about the Centre for Drug Discovery, please get in touch.